The new lawsuit argues that the board’s action conflicted with federal patent laws by not allowing the company to charge as much as it wants.

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

Pharmaceutical company Amgen sued the Colorado Prescription Drug Affordability Board over a price cap the board placed on Enbrel.

The pharmaceutical company Amgen is suing the Colorado Prescription Drug Affordability Board after the price of one of its ...

Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a ...

Drugmaker AbbVie sued the state in June because of Senate Bill 71, which forbade drug companies from limiting how many ...

Amgen on Tuesday reported quarterly financial results that beat Wall Street expectations, and raised its full-year outlook, ...

Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

What Happened: Khosla's recent move involves selling 890 shares of Amgen. This information is documented in a Form 4 filing ...

SEATTLE (AP) — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial ...